10x Genomics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for 10x Genomics, Inc. (TXG) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents0.340.390.220.590.660.42
Short-Term Investments0.050.030.210.000.000.00
Cash & Short-Term Investments0.390.390.430.590.660.42
Accounts Receivable0.090.110.100.090.050.03
Inventory0.080.070.080.060.030.02
Other Current Assets0.020.050.020.010.010.01
Total Current Assets0.580.600.640.750.770.48
Non-Current Assets
Property, Plant & Equipment (Net)0.310.340.360.230.120.04
Goodwill0.000.000.000.000.000.00
Intangible Assets0.020.020.020.030.020.00
Other Non-Current Assets0.000.000.010.010.010.08
Total Non-Current Assets0.330.370.390.270.150.11
Total Assets0.920.971.031.020.930.61
Current Liabilities
Accounts Payable0.010.070.020.020.000.05
Short-Term Debt0.020.000.000.000.000.00
Accrued Liabilities0.050.050.060.050.040.00
Deferred Revenue0.020.010.010.010.000.00
Other Current Liabilities0.060.030.010.020.060.00
Total Current Liabilities0.120.130.130.110.120.06
Non-Current Liabilities
Long-Term Debt0.070.080.090.080.060.07
Other Non-Current Liabilities0.010.000.000.010.020.00
Total Non-Current Liabilities0.090.100.090.090.070.16
Total Liabilities0.210.220.220.200.190.19
Stockholders' Equity
Common Stock0.000.000.000.000.000.00
Retained Earnings-1.47-1.28-1.03-0.86-0.81-0.26
Accumulated Other Comprehensive Income0.000.000.000.000.000.00
Additional Paid-in Capital2.182.031.841.681.540.68
Shares Outstanding0.120.120.120.110.000.00
Total Stockholders' Equity0.710.740.810.820.740.42
Total Liabilities & Equity0.920.971.031.020.930.61